Influence of two different beta-adrenergic blocking agents on the increase in fibrinolytic activity and factor VIII activity during submaximum and maximum exercise.
D000328:Adult; D000526:Alprenolol / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D005169:Factor VIII / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D010101:Oxygen Consumption; D005082:Physical Exertion; D010919:Placebos; D011433:Propranolol / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013997:Time Factors
D010919:Placebos; D000526:Alprenolol; D005169:Factor VIII; D011433:Propranolol